Botulinum neurotoxin injections are a common dystonia treatment. This is a highly specialized, ongoing therapy that must be customized to each patient. There are several factors than can influence outcome from treatment, degree of benefit, and chance of side effects.
Join us for a conversation about achieving optimal results from botulinum neurotoxin injections with movement disorder expert H. A. “Buz” Jinnah, MD, PhD, Professor, Emory University School of Medicine, Departments of Neurology & Human Genetics, and Director, Dystonia Coalition.
The program is relevant for individuals treated with any and all FDA-approved brands: Botox® (OnabotulinumtoxinA), Dysport®(AbobotulinumtoxinA), Myobloc® (RimabotulinumtoxinB), and Xeomin® (IncobotulinumtoxinA).
The webinar will be recorded and made available following the live broadcast.
This program is supported by Ipsen Biopharmaceuticals.